| scholarly article | Q13442814 |
| P50 | author | Grainne M. McAlonan | Q48969560 |
| Eric Yu-Hai Chen | Q58807068 | ||
| P2093 | author name string | Charlton Cheung | |
| Siew E Chua | |||
| John Suckling | |||
| Vinci Cheung | |||
| Jason P Y Cheung | |||
| Lawrance Yip | |||
| Kin-Shing Tai | |||
| Jack T K Tsang | |||
| Jason C H Wong | |||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 12-21 | |
| P577 | publication date | 2006-11-13 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Cerebral grey, white matter and csf in never-medicated, first-episode schizophrenia | |
| P478 | volume | 89 |
| Q36148525 | A Neuroanatomical Signature for Schizophrenia Across Different Ethnic Groups |
| Q81468516 | A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia |
| Q33706388 | A diffusion tensor imaging study of the anterior limb of the internal capsule in schizophrenia |
| Q48499474 | A naturalistic study of grey matter volume increase after early treatment in anti-psychotic naïve, newly diagnosed schizophrenia. |
| Q33525203 | A systematic review of the effects of antipsychotic drugs on brain volume |
| Q36386344 | Alterations in white matter evident before the onset of psychosis. |
| Q37019129 | Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia |
| Q31153621 | Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology |
| Q45247637 | Anatomical substrates of cognitive and clinical dimensions in first episode schizophrenia. |
| Q37093477 | Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy |
| Q34151554 | Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis. |
| Q95778857 | Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis |
| Q47304523 | Association between structural and functional brain alterations in drug-free patients with schizophrenia: a multimodal meta-analysis. |
| Q33330477 | Association of limbic system-associated membrane protein (LSAMP) to male completed suicide |
| Q48953087 | Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T. |
| Q33678755 | Autistic disorders and schizophrenia: related or remote? An anatomical likelihood estimation. |
| Q85839759 | Basal ganglia anatomy and schizophrenia: the role of antipsychotic treatment |
| Q34415969 | Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression |
| Q36660287 | Brain gray matter phenotypes across the psychosis dimension |
| Q33592537 | Brain pathology in first-episode psychosis: magnetization transfer imaging provides additional information to MRI measurements of volume loss |
| Q44278018 | Brain volume reductions in medication-naive patients with schizophrenia in relation to intelligence quotient |
| Q28285577 | Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia |
| Q33892176 | Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: a population-based study of first-episode psychosis |
| Q30645134 | Combination of Resting State fMRI, DTI, and sMRI Data to Discriminate Schizophrenia by N-way MCCA + jICA |
| Q48460836 | Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis. |
| Q44450890 | Concordance of white matter and gray matter abnormalities in autism spectrum disorders: a voxel-based meta-analysis study. |
| Q48111640 | Connectivity-based parcellation of the anterior limb of the internal capsule. |
| Q42451941 | Differential effects on white-matter systems in high-functioning autism and Asperger's syndrome. |
| Q36814158 | Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? |
| Q48960835 | Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. |
| Q39340879 | Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia |
| Q50724485 | Elevated mRNA expression of CASPR3 in patients with schizophrenia. |
| Q30482411 | Endophenotypes in schizophrenia: a selective review |
| Q33828632 | Frontal-subcortical protein expression following prenatal exposure to maternal inflammation. |
| Q37215695 | Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study |
| Q48155090 | Gray matter alterations in first-admission adolescents with schizophrenia |
| Q47668735 | Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis |
| Q34415975 | Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. |
| Q47128142 | Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits |
| Q57536745 | Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects |
| Q24606392 | Gray matter volume in schizophrenia and bipolar disorder with psychotic features |
| Q34701102 | Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis |
| Q37241006 | Higher Adolescent Body Mass Index Is Associated with Lower Regional Gray and White Matter Volumes and Lower Levels of Positive Emotionality |
| Q35158156 | Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis |
| Q33712210 | Hippocampal and caudate volume reductions in antipsychotic-naive first-episode schizophrenia |
| Q30403790 | Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia |
| Q30459370 | Increased cell proliferation in the rat anterior cingulate cortex following neonatal hypoxia: relevance to schizophrenia |
| Q48420825 | Individual differences in EEG spectral power reflect genetic variance in gray and white matter volumes |
| Q28743868 | MRI study of minor physical anomaly in childhood autism implicates aberrant neurodevelopment in infancy |
| Q33950987 | Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness |
| Q48577735 | Multimodal MRI reveals structural connectivity differences in 22q11 deletion syndrome related to impaired spatial working memory. |
| Q92141004 | Neuroanatomical abnormalities in first-episode psychosis across independent samples: a multi-centre mega-analysis |
| Q46146851 | Neuroanatomical markers of genetic liability to psychosis and first episode psychosis: a voxelwise meta-analytical comparison |
| Q36740424 | Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. |
| Q28730843 | No association of COMT (Val158Met) genotype with brain structure differences between men and women |
| Q35099681 | Patterns of cerebellar volume loss in dementia with Lewy bodies and Alzheimer׳s disease: A VBM-DARTEL study. |
| Q39646600 | Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness |
| Q30488086 | Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model |
| Q37157851 | Psychiatric research: psychoproteomics, degradomics and systems biology |
| Q35087719 | Recovery of behavioral changes and compromised white matter in C57BL/6 mice exposed to cuprizone: effects of antipsychotic drugs |
| Q50777882 | Reduction of cerebellar grey matter in Crus I and II in schizophrenia. |
| Q37258056 | Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia |
| Q33560201 | Relationship between Interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-naïve schizophrenia: evidence for differential susceptibility? |
| Q35753625 | Restraint of appetite and reduced regional brain volumes in anorexia nervosa: a voxel-based morphometric study |
| Q52381884 | Schizophrenia moderates the relationship between white matter integrity and cognition. |
| Q44305005 | Structural brain abnormalities in first-episode psychosis: differences between affective psychoses and schizophrenia and relationship to clinical outcome. |
| Q34369803 | Structural brain changes in First Episode Schizophrenia compared with Fronto-Temporal Lobar Degeneration: a meta-analysis |
| Q90256318 | Subcortical Brain Volume Abnormalities in Individuals With an At-risk Mental State |
| Q37228315 | Temporal lobe volume abnormalities precede the prodrome: a study of children presenting antecedents of schizophrenia |
| Q33865677 | The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis |
| Q35154166 | The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial |
| Q45942059 | The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. |
| Q48952912 | The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. |
| Q33585219 | The efficacy of a voxel-based morphometry on the analysis of imaging in schizophrenia, temporal lobe epilepsy, and Alzheimer's disease/mild cognitive impairment: a review |
| Q48696487 | The optic radiation and the cerebellar peduncles in adolescents with first-admission schizophrenia--a diffusion tensor imaging study |
| Q34147502 | The timing and specificity of prenatal immune risk factors for autism modeled in the mouse and relevance to schizophrenia. |
| Q30484045 | Three-dimensional brain growth abnormalities in childhood-onset schizophrenia visualized by using tensor-based morphometry |
| Q89158516 | Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity |
| Q37896626 | Understanding aberrant white matter development in schizophrenia: an avenue for therapy? |
| Q43762923 | Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. |
| Q24187709 | Voxel-based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis |
| Q36169035 | White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia |
| Q35932602 | White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study. |
| Q87945859 | [Frontal brain volume reduction due to antipsychotic drugs?] |
Search more.